Cargando…
A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia
Hydroxyurea is an antimetabolite drug that induces fetal haemoglobin in sickle cell disease. However, its clinical usefulness in β-thalassaemia is unproven. We conducted a randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of hydroxyurea in transfusion-de...
Autores principales: | Yasara, Nirmani, Wickramarathne, Nethmi, Mettananda, Chamila, Silva, Ishari, Hameed, Nizri, Attanayaka, Kumari, Rodrigo, Rexan, Wickramasinghe, Nirmani, Perera, Lakshman, Manamperi, Aresha, Premawardhena, Anuja, Mettananda, Sachith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854735/ https://www.ncbi.nlm.nih.gov/pubmed/35177777 http://dx.doi.org/10.1038/s41598-022-06774-8 |
Ejemplares similares
-
Efficacy and safety of oral hydroxyurea in transfusion-dependent β-thalassaemia: a protocol for randomised double-blind controlled clinical trial
por: Yasara, Nirmani, et al.
Publicado: (2020) -
A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic
por: Yasara, Nirmani, et al.
Publicado: (2021) -
Anaemia among females in child-bearing age: Relative contributions, effects and interactions of α- and β-thalassaemia
por: Mettananda, Sachith, et al.
Publicado: (2018) -
Body iron status of children and adolescents with transfusion dependent β-thalassaemia: trends of serum ferritin and associations of optimal body iron control
por: Suriapperuma, Tharindi, et al.
Publicado: (2018) -
Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study
por: Mettananda, Sachith, et al.
Publicado: (2019)